Mevopur™ Healthcare Functional Additives Mevopur™ Healthcare Functional Additives Mevopur™ Bio-based Polymer Solutions

Mevopur™ Healthcare Functional Additives Mevopur™ Healthcare Functional Additives Mevopur™ Bio-based Polymer Solutions

Mevopur™ Healthcare Functional Additives Mevopur™ Healthcare Functional Additives Mevopur™ Bio-based Polymer Solutions

Mevopur™ Healthcare Functional Additives Mevopur™ Healthcare Functional Additives Mevopur™ Bio-based Polymer Solutions

Mevopur™ Healthcare Functional Additives Mevopur™ Healthcare Functional Additives Mevopur™ Bio-based Polymer Solutions

Mevopur™ Healthcare Functional Additives Mevopur™ Healthcare Functional Additives Mevopur™ Bio-based Polymer Solutions

NOTE: On July 1, 2020, PolyOne and Clariant Masterbatch joined together as Avient, a new kind of materials company focused on conquering customer challenges and unlocking the potential for innovation and sustainability around the globe. ADDITIONAL INFORMATION: On pace for exponential growth, 5G technology is becoming the standard for a fully mobile and networked society through larger data capacity, faster speeds and lower latency.

BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF AMENDMENT OF “CLARIANT PLASTICS & COATINGS USA LLC”, CHANGING ITS NAME FROM "CLARIANT PLASTICS & COATINGS USA LLC" TO "AVIENT COLORANTS USA LLC", FILED IN THIS OFFICE ON THE ELEVENTH DAY OF JANUARY, A.D. 2021, AT 10:39 O`CLOCK A.M.

MEVOPUR Bio-based Solutions Application Bulletin_CN5.30-1 生物基聚合物解决方案 可持续发展关注的焦点 生物聚合物 应用公告 用于医疗器械和药品包装的MEVOPUR™ 越来越多的医疗器械和药品包装制造商面临着将 可持续性融入其产品设计的挑战。

Strong past performance demonstrates that our strategy and execution are working • Megatrends align with our strengths • Innovation and services provide differentiation and competitive advantage • Strong and proven management team driving growth and performance • Addressable market exceeds $40 billion The New PolyOne: A Specialty Growth Company 2015 Target: $2.50 Adjusted EPS Page 15 Schedule I Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in accordance with U.S. Average Debt Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average PolyOne Debt $ 705.8 $ 705.2 $ 706.9 $ 1,055.5 $ 1,031.2 $ 840.9 Average Equity Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average PolyOne shareholders’ equity $ 604.3 $ 629.3 $ 629.1 $ 871.8 $ 993.9 $ 745.7 Platform sales and operating income (OI) H1 2012*** H1 2013*** H1 2013**** Global Specialty Engineered Materials Sales $ 280.9 $ 352.0 $ 285.1 Global Color, Additives and Inks Sales 413.9 434.7 409.2 Designed Structures & Solutions Sales - 240.4 - Specialty Platform Sales $ 694.8 $ 1,027.1 $694.3 Performance Products and Solutions Sales 336.0 336.7 317.5 PolyOne Distribution Sales 533.6 543.1 543.1 Corporate and Eliminations (62.3) (68.2) (68.2) Total Sales $ 1,502.1 $ 1,838.7 $ 1,486.7 Global Specialty Engineered Materials OI $ 24.6 $ 32.5 $ 31.2 Global Color, Additives and Inks OI 44.0 54.7 52.0 Designed Structures & Solutions OI - 10.5 - Specialty Platform OI $ 68.6 $ 97.7 $ 83.2 Performance Products and Solutions OI 19.3 27.5 25.7 PolyOne Distribution OI 33.4 33.1 33.1 Corporate and eliminations (20.3) (25.7) (20.3) Special items in OI (20.3) (11.4) (20.3) Operating income - GAAP $ 80.7 $ 121.2 $ 101.4 Special items in OI 20.3 11.4 20.3 Operating income adjusted $ 101.0 $ 132.6 $ 121.7 Global Specialty Engineered Materials - OI % of sales 8.8% 9.2% 10.9% Global Color, Additives and Inks - OI % of sales 10.6% 12.6% 12.7% Designed Structures & Solutions - OI % of sales - 4.4% - Specialty platform - OI % of sales 9.9% 9.5% 12.0% PP&S operating - OI % of sales 5.7% 8.2% 8.1% Distribution OI - % of sales 6.3% 6.1% 6.1% PolyOne OI adjusted - % of sales 6.7% 7.2% 8.2% Reconciliation to Condensed Consolidated Balance Sheets H1 2013 Short-term debt and current portion of long-term debt $ 8.7 Long-term debt 1,022.5 Less cash and cash equivalents (392.4) Specialty Platform Gross Margin Percentage 2006Y* Q2 2013**** Global Specialty Engineered Materials Sales $ 345.3 $ 143.5 Global Color, Additives and Inks Sales 531.8 207.5 Specialty Platform Sales $ 877.1 $ 351.0 Global Specialty Engineered Materials Gross Margin $ 41.6 $ 37.3 Global Color, Additives and Inks Gross Margin 83.6 71.8 Specialty Platform Gross Margin $ 125.2 $ 109.1 Specialty Platform Gross Margin Percentage 14.3% 31.1% * Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment. Credit Suisse September 2013 Investor Presentation non-GAAP v2.pdf Reconciliation to Condensed Consolidated Balance Sheets